Adaptimmune Therapeutics PLC Annual Return On Assets in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Adaptimmune Therapeutics PLC quarterly/annual Return On Assets history and growth rate from 2016 to 2023.
  • Adaptimmune Therapeutics PLC Return On Assets for the quarter ending June 30, 2024 was -25 %, a 11.2% increase year-over-year.
  • Adaptimmune Therapeutics PLC annual Return On Assets for 2023 was -37.6 %, a 16.5% increase from 2022.
  • Adaptimmune Therapeutics PLC annual Return On Assets for 2022 was -45.1 %, a 15.7% decline from 2021.
  • Adaptimmune Therapeutics PLC annual Return On Assets for 2021 was -38.9 %, a 29.2% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -37.6 +7.41 +16.5% Jan 1, 2023 Dec 31, 2023
2022 -45.1 -6.12 -15.7% Jan 1, 2022 Dec 31, 2022
2021 -38.9 -8.81 -29.2% Jan 1, 2021 Dec 31, 2021
2020 -30.1 +30.9 +50.6% Jan 1, 2020 Dec 31, 2020
2019 -61 -24.4 -66.7% Jan 1, 2019 Dec 31, 2019
2018 -36.6 -11.8 -47.6% Jan 1, 2018 Dec 31, 2018
2017 -24.8 +5.11 +17.1% Jan 1, 2017 Dec 31, 2017
2016 -29.9 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.